# Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome

> **NCT00406445** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 82 (actual)

## Conditions studied

- Mitochondrial Disorders
- Li-Fraumeni Syndrome
- Carriers of p53 Mutation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00406445
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-23
- **Primary completion:** 2021-03-22
- **Final completion:** 2021-03-22
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2021-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406445, "Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00406445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*